KRYSTAL RILEY: Open Payments
NPI 1053810101 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$908 in 55 payments from 11 companies in 2025. Trend: 2023 $500 · 2024 $974 · 2025 $908
Food & beverage: $908
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $348 |
| ABBVIE INC. | 14 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $114 |
| Phathom Pharmaceuticals, Inc. | 6 | $69 |
| Exact Sciences Corporation | 3 | $51 |
| PFIZER INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $34 |
| Novo Nordisk Inc | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $18 |
Products named: BREZTRI, CAPLYTA, VRAYLAR, FARXIGA, AIRSUPRA, VOQUEZNA, QULIPTA, MOUNJARO.
Industry payments across AR — which companies pay providers there.
